Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

Innovations in Forensic Examination of Seized Drugs and Forensic Toxicology

NewsMed interviews Michelle Peace on her Pittcon presentation entitled, "Innovations in Forensic Examination of Seized Drugs and Forensic Toxicology".

From Pittcon 15 Feb 2021

Algorithm for skin cancer diagnosis performs on par with dermatologists

A study has now been presented that boosts the evidence for using AI solutions in skin cancer diagnostics.

13 Feb 2021

Akkure Genomics raises €1.2 million to accelerate roll-out of its next-generation clinical trials platform

Akkure Genomics, an Irish digital health scaleup which is developing a disruptive MedTech platform for the global clinical trials industry, has raised just over €1.2 million in a crowdfunding campaign from 318 investors.

13 Feb 2021

AI-assisted video analysis can help doctors to diagnose Parkinson’s disease at an early stage

Scientists from Skoltech and A.I. Burnazyan Federal Medical and Biophysical Center have designed and developed a second opinion system, based on AI-assisted video analysis, which can help medical professionals to objectively assess patients with Parkinson’s disease (PD) even at an early stage.

12 Feb 2021

Reparations before COVID-19 pandemic could have reduced infections, deaths in the U.S.

Civil rights activists have long called for monetary reparations to the Black descendants of Africans enslaved in the United States as a financial, moral, and ethical form of restitution for the injustices of slavery.

12 Feb 2021

Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine

Deep Longevity, a fully-owned subsidiary of Regent Pacific (SEHK:0575.HK), specializing in the development and the application of next-generation artificial intelligence (AI) for aging and longevity research, today announced the publication of an article in Lancet Healthy Longevity titled "The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19".

11 Feb 2021

Metabolomics and machine learning used to identify possible COVID-19 biomarkers

One of the many mysteries still surrounding COVID-19 is why some people experience only mild, flu-like symptoms, whereas others suffer life-threatening respiratory problems, vascular dysfunction and tissue damage.

10 Feb 2021

Taking Advantage of Measuring Molecular Collisional Cross-Sections in Pharma

News-Medical talks to Mike Greig, Director of Pharma at Bruker, about why measuring collisional cross-sections is beneficial to developing new drugs.

From Bruker Life Sciences Mass Spectrometry 10 Feb 2021

Optibrium Raises Investment to Advance Computer-Aided Drug Discovery

Optibrium™ today announced it has raised significant investment from Kester Capital.

From Optibrium Ltd. 10 Feb 2021

UCI Health creates new system to deliver monoclonal antibodies in COVID-19 patients

Monoclonal antibodies are showing promise for improving outcomes for COVID-19 patients, but when a hospital is already beyond capacity, administering them can be a challenge.

10 Feb 2021

Model estimates COVID-19 cases in the U.S. to be three times greater than reported

World health experts have long suspected that the incidence of COVID-19 has been higher than reported.

9 Feb 2021

People with dementia found to have significantly increased risk for COVID-19

A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19 - and the risk was higher still for African Americans with dementia.

9 Feb 2021

Drinking one or more cups of caffeinated coffee may reduce heart failure risk

Dietary information from three large, well-known heart disease studies suggests drinking one or more cups of caffeinated coffee may reduce heart failure risk, according to research published today in Circulation: Heart Failure, an American Heart Association journal.

9 Feb 2021

Smell and taste loss symptoms associated with robust SARS-CoV-2 antibody response in new study

Researchers in Italy report a correlation between the loss of smell and taste and an observed persistence or rise in antibody levels at five months after infection.

9 Feb 2021

Tecan and UgenTec partner to offer sample-to-result solutions for qPCR

Tecan and laboratory software specialist UgenTec have announced a collaboration to develop fully integrated, sample-to-result solutions for PCR workflows.

From Tecan 9 Feb 2021

New book highlights need for rapid, frequent screening to control the pandemic

Covid-19 is a global pandemic inflicting large health and economic costs. In his previous book, The Pandemic Information Gap: The Brutal Economics of COVID-19 (The MIT Press, 2020), economist Joshua Gans explains that those costs have been so large because governments and others have lacked the information needed to control the pandemic.

9 Feb 2021

Study provides key insight into the neural mechanism of attention selection in primates

This discovery was made possible by applying the research method for the comparison of the brain activity between monkeys and humans to artificial neural networks.

9 Feb 2021

Pancreatic β cells secrete miR-29 in response to high levels of free fatty acids

In a new study published in Journal of Extracellular Vesicles, Chen-Yu Zhang's group and Antonio Vidal-Puig's group at University of Cambridge report that pancreatic β cells secrete miR-29 family members (miR-29a, miR-29b and miR-29c) in response to high levels of free fatty acids (FFAs). These β cell-derived miR-29s are delivered to the liver, promoting insulin resistance and enhancing hepatic glucose output.

9 Feb 2021

New machine-learning algorithm estimates number of COVID-19 cases in the U.S.

World health experts have long suspected that the incidence of COVID-19 has been higher than reported. Now, a machine-learning algorithm developed at UT Southwestern estimates that the number of COVID-19 cases in the U.S. since the pandemic began is nearly three times that of confirmed cases.

8 Feb 2021

New platform could help advance genomic medicine research, drug discovery

A Cleveland Clinic-led team of researchers has developed a personalized genomic medicine platform that will help advance accelerate genomic medicine research and genome-informed drug discovery, according to new study results published recently in Genome Biology.

8 Feb 2021

Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

Innovations in Forensic Examination of Seized Drugs and Forensic Toxicology

Algorithm for skin cancer diagnosis performs on par with dermatologists

Akkure Genomics raises €1.2 million to accelerate roll-out of its next-generation clinical trials platform

AI-assisted video analysis can help doctors to diagnose Parkinson’s disease at an early stage

Reparations before COVID-19 pandemic could have reduced infections, deaths in the U.S.

Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine

Metabolomics and machine learning used to identify possible COVID-19 biomarkers

Taking Advantage of Measuring Molecular Collisional Cross-Sections in Pharma

Optibrium Raises Investment to Advance Computer-Aided Drug Discovery

UCI Health creates new system to deliver monoclonal antibodies in COVID-19 patients

Model estimates COVID-19 cases in the U.S. to be three times greater than reported

People with dementia found to have significantly increased risk for COVID-19

Drinking one or more cups of caffeinated coffee may reduce heart failure risk

Smell and taste loss symptoms associated with robust SARS-CoV-2 antibody response in new study

Tecan and UgenTec partner to offer sample-to-result solutions for qPCR

New book highlights need for rapid, frequent screening to control the pandemic

Study provides key insight into the neural mechanism of attention selection in primates

Pancreatic β cells secrete miR-29 in response to high levels of free fatty acids

New machine-learning algorithm estimates number of COVID-19 cases in the U.S.

New platform could help advance genomic medicine research, drug discovery

AI In Healthcare eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

AI In Healthcare eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in